Innoveix Pharmaceuticals Inc: Drug Recall
Recall #D-0692-2021 · 07/09/2021
Class II: Risk
Recall Details
- Recall Number
- D-0692-2021
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Innoveix Pharmaceuticals Inc
- Status
- Completed
- Date Initiated
- 07/09/2021
- Location
- Addison, TX, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 728 vials
Reason for Recall
Lack of Assurance of Sterility
Product Description
Compounded Lyophilized Semorelin/Ipamorelin 3 mg For subcutaneous or intramuscular injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910
Distribution Pattern
Nationwide within the United States
Other Recalls by Innoveix Pharmaceuticals Inc
- Class II: Risk 07/09/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.